Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

A Health Intervention to Prevent Depression Hepatitis C Patients
An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C
Status: Enrolling
Updated:  12/28/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
A Health Intervention to Prevent Depression Hepatitis C Patients
An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C
Status: Enrolling
Updated: 12/28/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
Preventing Depression in MMT Patients on Interferon
Status: Enrolling
Updated:  1/11/2017
Rhode Island Hospital
mi
from
Providence, RI
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
Preventing Depression in MMT Patients on Interferon
Status: Enrolling
Updated: 1/11/2017
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Integrated Treatment for Cocaine and Mood Disorders - 1
ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders
Status: Enrolling
Updated:  1/11/2017
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Integrated Treatment for Cocaine and Mood Disorders - 1
ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders
Status: Enrolling
Updated: 1/11/2017
University of Texas Health Sci Cntr Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings
Status: Enrolling
Updated:  1/12/2017
NYSPI
mi
from
New York, NY
Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings
Status: Enrolling
Updated: 1/12/2017
NYSPI
mi
from
New York, NY
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Sherman Oaks, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Temecula, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Denver, CO
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Cromwell, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Cromwell, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Hamden, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Hamden, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Middletown, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Middletown, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Miami, FL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Marietta, GA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Rockville, MD
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Ridgeland, MS
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Ridgeland, MS
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Beachwood, OH
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Beachwood, OH
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Portland, OR
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Lincoln, RI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Lincoln, RI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Austin, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Dallas, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Houston, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Lake Jackson, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
San Antonio, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
Status: Enrolling
Updated:  1/23/2017
Advanced Clinical Laboratory Solutions, Inc.
mi
from
Brooklyn, NY
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
Status: Enrolling
Updated: 1/23/2017
Advanced Clinical Laboratory Solutions, Inc.
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated:  2/6/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated: 2/6/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Synergy San Diego
mi
from
National City, CA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Synergy San Diego
mi
from
National City, CA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
Status: Enrolling
Updated:  3/29/2017
San Joaquin General Hospital
mi
from
Stockton, CA
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
Status: Enrolling
Updated: 3/29/2017
San Joaquin General Hospital
mi
from
Stockton, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Woodland Research Northwest, LLC
mi
from
Springdale, AR
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Woodland Research Northwest, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions Inc. - Jacksonville
mi
from
Jacksonville, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions Inc. - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions Inc. - Orlando
mi
from
Orlando, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions Inc. - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials